These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35830207)

  • 21. Roles of peroxisome proliferator-activated receptor-alpha and -gamma in the development of non-small cell lung cancer.
    Li MY; Yuan H; Ma LT; Kong AW; Hsin MK; Yip JH; Underwood MJ; Chen GG
    Am J Respir Cell Mol Biol; 2010 Dec; 43(6):674-83. PubMed ID: 20081051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of PPARγ in myeloid cells promotes lung cancer progression and metastasis.
    Li H; Sorenson AL; Poczobutt J; Amin J; Joyal T; Sullivan T; Crossno JT; Weiser-Evans MC; Nemenoff RA
    PLoS One; 2011; 6(12):e28133. PubMed ID: 22145026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice.
    Khan N; Afaq F; Kweon MH; Kim K; Mukhtar H
    Cancer Res; 2007 Apr; 67(7):3475-82. PubMed ID: 17389758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical evidence for pioglitazone and bexarotene combination in oral cancer chemoprevention.
    Rosas RR; Nachbor KM; Handley N; Mathison G; Wuertz BR; Ba'th F; Ondrey FG
    Head Neck; 2022 Mar; 44(3):661-671. PubMed ID: 34931381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung.
    Prudkin L; Liu DD; Ozburn NC; Sun M; Behrens C; Tang X; Brown KC; Bekele BN; Moran C; Wistuba II
    Mod Pathol; 2009 May; 22(5):668-78. PubMed ID: 19270647
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection and quantification of epithelial progenitor cell populations in human healthy and IPF lungs.
    Smirnova NF; Schamberger AC; Nayakanti S; Hatz R; Behr J; Eickelberg O
    Respir Res; 2016 Jul; 17(1):83. PubMed ID: 27423691
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneous nuclear ribonucleoprotein B1 as early cancer biomarker for occult cancer of human lungs and bronchial dysplasia.
    Sueoka E; Sueoka N; Goto Y; Matsuyama S; Nishimura H; Sato M; Fujimura S; Chiba H; Fujiki H
    Cancer Res; 2001 Mar; 61(5):1896-902. PubMed ID: 11280744
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pioglitazone prevents smoking carcinogen-induced lung tumor development in mice.
    Li MY; Kong AW; Yuan H; Ma LT; Hsin MK; Wan IY; Underwood MJ; Chen GG
    Curr Cancer Drug Targets; 2012 Jul; 12(6):597-606. PubMed ID: 22463586
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene Expression Profiling Revealed 2 Types of Bronchial Basal Cell Hyperplasia and Squamous Metaplasia With Different Progression Potentials.
    Denisov EV; Schegoleva AA; Gerashchenko TS; Skryabin NA; Sleptcov AA; Yakushina VD; Lyapunova LS; Tuzikov SA; Pankova OV; Perelmuter VM
    Appl Immunohistochem Mol Morphol; 2020 Jul; 28(6):477-483. PubMed ID: 30896548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. β-Catenin determines upper airway progenitor cell fate and preinvasive squamous lung cancer progression by modulating epithelial-mesenchymal transition.
    Giangreco A; Lu L; Vickers C; Teixeira VH; Groot KR; Butler CR; Ilieva EV; George PJ; Nicholson AG; Sage EK; Watt FM; Janes SM
    J Pathol; 2012 Mar; 226(4):575-87. PubMed ID: 22081448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential effects of PPARgamma activation by the oral antidiabetic agent pioglitazone in Barrett's carcinoma in vitro and in vivo.
    Al-Taie OH; Graf T; Illert B; Katzenberger T; Mörk H; Kraus MR; Barthelmes HU; Scheurlen M; Seufert J
    J Gastroenterol; 2009; 44(9):919-29. PubMed ID: 19506796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CB11, a novel purine-based PPARɣ ligand, overcomes radio-resistance by regulating ATM signalling and EMT in human non-small-cell lung cancer cells.
    Kim TW; Hong DW; Park JW; Hong SH
    Br J Cancer; 2020 Dec; 123(12):1737-1748. PubMed ID: 32958825
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of macrophage-dependent peroxisome proliferator-activated receptor γ signalling on adhesion formation after abdominal surgery in an experimental model.
    Hong GS; Schwandt T; Stein K; Schneiker B; Kummer MP; Heneka MT; Kitamura K; Kalff JC; Wehner S
    Br J Surg; 2015 Nov; 102(12):1506-16. PubMed ID: 26313905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TGFβ can stimulate the p(38)/β-catenin/PPARγ signaling pathway to promote the EMT, invasion and migration of non-small cell lung cancer (H460 cells).
    Lin LC; Hsu SL; Wu CL; Hsueh CM
    Clin Exp Metastasis; 2014 Dec; 31(8):881-95. PubMed ID: 25168821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epithelial mesenchymal transition (EMT) and non-small cell lung cancer (NSCLC): a mutual association with airway disease.
    Mahmood MQ; Ward C; Muller HK; Sohal SS; Walters EH
    Med Oncol; 2017 Mar; 34(3):45. PubMed ID: 28197929
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PPARγ-Mediated p21 Induction in Aerodigestive Preneoplastic Cell Lines.
    Miller WA; Wuertz BR; Ondrey FG
    Ann Otol Rhinol Laryngol; 2018 Oct; 127(10):677-686. PubMed ID: 30047791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aberrant expression of p53 or the epidermal growth factor receptor is frequent in early bronchial neoplasia and coexpression precedes squamous cell carcinoma development.
    Rusch V; Klimstra D; Linkov I; Dmitrovsky E
    Cancer Res; 1995 Mar; 55(6):1365-72. PubMed ID: 7882337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.
    Argon A; Nart D; Veral A
    Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An expression of squamous cell carcinoma antigen 2 in peripheral blood within the different stages of esophageal carcinogenesis.
    Yang YF; Li H; Xu XQ; Diao YT; Fang XQ; Wang Y; Zhao DL; Wu K; Li HQ
    Dis Esophagus; 2008; 21(5):395-401. PubMed ID: 19125792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Randomized Phase II Trial of Pioglitazone for Lung Cancer Chemoprevention in High-Risk Current and Former Smokers.
    Keith RL; Blatchford PJ; Merrick DT; Bunn PA; Bagwell B; Dwyer-Nield LD; Jackson MK; Geraci MW; Miller YE
    Cancer Prev Res (Phila); 2019 Oct; 12(10):721-730. PubMed ID: 31308004
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.